⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Mark PassMD

Geriatric Medicine · Manalapan, NJ 07726

NPI: 1437156288

Share:

29

🟡 Moderate

Risk Flags

Elevated long-acting opioid rateHigh antipsychotic prescribing (65+)Opioid + benzodiazepine co-prescriberHigh fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

47,482

Total Claims

$3.8M

Drug Cost

1,719

Beneficiaries

$2,202

Cost/Patient

Risk Score Breakdown 29/100

Low (0)Moderate (15)Elevated (30)High (50+)
Elderly antipsychotic prescribing+10
Opioid + benzodiazepine combo+8
Long-acting opioid rate+4
High fills per patient+3

Score components are additive. Read full methodology

Peer Comparison vs. 1,825 Geriatric Medicine providers

-52%

Opioid rate vs peers

1.2% vs 2.6% avg

+78%

Cost per patient vs peers

$2,202 vs $1,237 avg

+54%

Brand preference vs peers

14.2% vs 9.2% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

1.2%

Opioid Rate

588

Opioid Claims

$65K

Opioid Cost

25.2%

Long-Acting Rate

Brand vs Generic

86% generic

Brand: 6,653 claims · $2.8M

Generic: 40,310 claims · $975K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Apixaban1,286$589K
Rivaroxaban519$261K
Sitagliptin Phosphate245$148K
Insulin Aspart170$119K
Mirabegron202$108K
Semaglutide88$102K
Fluticasone/Umeclidin/Vilanter105$86K
Insulin Glargine,hum.Rec.Anlog278$84K
Empagliflozin158$82K
Fluticasone/Vilanterol166$66K
Lipase/Protease/Amylase97$48K
Dapagliflozin Propanediol110$48K
Insulin Lispro111$43K
Semaglutide33$41K
Sacubitril/Valsartan56$37K

Prescribing Profile

305

Unique Drugs

$1.3M

IRA Negotiated Drugs

$195K

GLP-1 Drugs

29.0

Anomaly Score

Patient Profile

84

Avg Age

68%

Female

2.18

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data